[1]
Jia, Y., Zang, A., Feng, Y., Li, X.-F., Zhang, K., Li, H., Wang, R., Wei, Y. and Huo, R. 2016. miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis. Bangladesh Journal of Pharmacology. 11, 1 (Jan. 2016), 264–268. DOI:https://doi.org/10.3329/bjp.v11i1.25318.